<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">




Addressing Direct-to-Patient Clinical Supply Challenges Through Speed and Flexibility

Tuesday, April 20th | 9:00am EST | 15:00 CET

In Partnership with IMP Logo-1

Covid-19 has led to accelerated development in Direct-to-Patient (DtP) models for clinical trial studies, creating a growing need for cutting-edge technologies that allow for safe and rapid integration of these models. Delivering IMP to a patients’ home requires speed and flexibility to allow for seamless collaboration between the study team, sites, and depots on logistical challenges. Join Neta Bendelac from 4G Clinical and Limor Teomim from IMP CSS for an informative webinar as they explore how to mitigate the growing challenges faced as a result of the pandemic when it comes to DtP strategies and virtual trial design.

Webinar Objectives:
• Introduce and assess DtP models within a clinical trial
• Discuss industry challenges with DtP models in the current landscape
• Explore flexible DtP designs in modern Randomization and Trial Supply Management (RTSM) systems
• Explore the future of decentralized clinical trial design

Secure Your Seat






Screen Shot 2020-03-19 at 3.18.14 PM_burned


Limor Teomim Headshot Circle



Neta Bendelac

Senior Director, Strategy

4G Clinical



Limor Teomim


IMP - Clinical Supply Services Ltd.



Additional Resources


Modern Technologies
in Clinical Trials

Demystifying the use of Innovative RTSMs in a Highly-Regulated Environment

Download Now


Faster Study

How Natural Language Processing (NLP) is a game changer in Clinical Research

Download Now


Disrupting Study

How Agile RTSM Software Development Accelerates the Clinical Trial Timeline

Download Now